Rohit Kapoor
Analyst · Edward Caso, Wells Fargo
Thank you, Charlie, and thank you, everyone, for joining us on our second quarter earnings call. The agenda for this call will be as follows: first, I will discuss our second quarter performance and a few recent business highlights; second, I will provide an overview of the demand environment across our businesses and give color on our updated outlook for the second half of this year. I will then turn the call to Vishal for more detailed commentary on our financial results and outlook. Following this, we will be happy to take your questions. Second quarter results were slightly better than expected on a constant currency basis, with constant currency revenues being $1 million higher than on a reported basis. As expected, revenues were flattish sequentially. Modestly better than forecasted volume growth in our outsourcing business was offset by a sharp depreciation in the Indian rupee versus the U.S. dollar and weaker-than-expected project-based revenue in transformation services. In the second quarter, EXL expanded its capabilities in several key delivery locations. We added clinical operations management delivery capability in Kochi, India, supplementing our strong clinical presence in the Philippines. Our new center in Cebu in the Philippines had a solid start and adding to our existing and rapidly growing delivery centers in Manila. While the growth of our transformation business was somewhat subdued in the second quarter, we are encouraged by the fact that our Decision Analytics business grew 5% sequentially. This sequential growth was driven by new client relationships in health care and growth in existing client relationships in banking and financial services, particularly some of the large relationships we won last year. We are encouraged by the momentum we see in this business in the second half of the year. Since our earnings call, EXL has had several accomplishments in the marketplace, validating our domain expertise in our targeted verticals. I would like to mention 3 in life insurance and 3 in health care. In life insurance, we were presented with the Excellence in Education Award from the Life Office Management Association or LOMA, pertaining to training we provide our employees. This award, typically given to insurers, demonstrates our intellectual property in educating our employees and getting them certified on insurance industry standards. To date, EXL's in-house insurance academy has trained over 400 LOMA certified professionals and over 8,500 employees since its inception. Additionally, we were honored to be named Genworth Financial's Supplier of the Year for Value Creation for our management of their variable annuity business, including transitioning all variable annuity servicing during 2012 within committed timelines and with no negative service impact. Leveraging an onshore and offshore model to deliver the highest quality operations management services on a complex insurance product like variable annuities is a testament to our disciplined process management capabilities and domain expertise in this vertical. Finally, in the second quarter, Gartner positioned EXL's LifePro platform in the Leaders quadrant in their report, Magic Quadrant for North American Life Insurance Policy Administration Systems published in June. We see a bright future ahead for LifePro as insurance firms look to trusted providers to handle administration of policies in a range of products from term and whole life, to annuities, to disability insurance, to long-term care. Turning to healthcare. First, EXL finished second out of over 1,500 participants in the Heritage Health challenge, a global predictive modeling competition designed to develop analytics-based solutions to decrease the number of avoidable hospital visits in the United States. The highly proprietary algorithms and models we develop here demonstrate our thought leadership in healthcare. Second, during this quarter, EXL was named a High Performer in Healthcare's Payer BPO by Horses for Sources. Third, we were recently selected by a leading Blue Cross Blue Shield health insurance provider to implement EXL Landa's CareRadius medical management platform. This substantial deal not only adds millions of members to CareRadius, but also validates our acquisition of Landacorp last year and is a strong indicator of EXL's leadership in the healthcare domain. Our leadership position in insurance and healthcare continues to be strong, and I am pleased with how we are performing in the market in these verticals. Turning to EXL's demand environment. During the second quarter, the pipeline in finance and accounting was the most active by far. We recently won a good sized F&A deal and are in an excellent position on a number of other F&A deals across a range of verticals with marquee clients. Our strategy in F&A is paying off well. Over the past 2 years, we acquired OPI and added deep skill sets and referenceable client relationships. Today, we are a major player in this business and the share of F&A deals in our overall deal pipeline has increased substantially. In the last month, we signed 2 material long-term contract expansions in our outsourcing business, which will begin ramping up later this year. One is in our travel domain and one is in healthcare. Both are for highly complex, industry-specific operations management services. We won these deals because of our strong client relationships, focused domain expertise and tangible business impact that we make for our clients. Looking ahead, our pipeline remains strong across our businesses. Among our existing clients who fuel the majority of our revenue growth in a particular year, our deal pipelines are particularly strong in operations management for insurance, healthcare and banking and financial services, as well as in decision analytics. Among new prospects in our pipeline, demand for financial accounting, insurance and healthcare and decision analytics is strong. Our pipeline continues to include very large deals from both new and existing clients across industry verticals. In the next several years, we see product management, operations consulting and partnerships playing a larger role in how we go to market. Over the last year, we have invested heavily in our capabilities here, including in a dedicated products and partnerships group. A recent success from this team comes from our insurance business. EXL's medical records and attending physician summarization solution was launched in the second quarter. This tool, designed for insurance claims adjusters and customer specialists, synthesizes the many disparate medical records and insurance claims department users into a highly usable centralized tool with embedded analytics. It provides actionable insights to claims adjusters and all key information in one single place to drive better productivity, accuracy and efficiency. In the next several quarters, we expect to expand EXL's ecosystem through several more partnerships with best-of-breed technology providers. In the second quarter, we announced a partnership with GT Nexus to provide comprehensive services to the global supply chain industry. Now turning to our expectations for the second half of this year. As you would have read in our earnings press release, we are revising our 2013 revenue forecast to $475 million to $483 million, and our 2013 adjusted diluted EPS forecast to $1.71 to $1.79 per share. This revision is driven by 3 factors. First, recent rupee depreciation caused a $6 million forecast change to the portion of our revenues where clients assume foreign exchange risk. EXL's profit before tax is neutral to changes in FX, which is the goal of our hedging strategy. Second, project-based spending remains cautious. This is the largest reason for the decline in our guidance. As you all know, even though project-based revenue is a small percentage of EXL's revenue, it is highly volatile. Such spending was subdued in the first half of the year, and we now expect it to be subdued in the second half of the year as well. Third, we have seen slower-than-expected business ramp-ups. The slower-than-expected business ramp-ups are due both to delayed decision-making and clients preferring to start relationships with smaller value pilots than we previously anticipated. For example, recently we have engaged 4 marquee clients on small pilots. Each one of these pilots has the potential to lead to substantial long-term relationships down the road. However, in the current year, they will contribute little revenue. Looking ahead, our key secular growth engines remain healthy. Our client relationships are large and growing, with the leaders in our industry and in our targeted industries. Many of these relationships are highly underpenetrated with EXL in the best position to expand. We continue to enjoy a robust pipeline for future business. Both the number of deals we are seeing and the average size of deals is increasing nicely. Corporations are turning in unprecedented fashion to industry expert service providers like EXL, who can apply tested operations management expertise using a global network of professionals to capitalize our competitive edge. Our analytics and platform technology businesses are highly differentiated and leaders in our targeted industries. Coupled with our heritage of operations management leadership, these new businesses make us an attractive alternate for clients as a strategic partner. We look forward to acceleration in the second half of this year, driven by our expectation for broad-based volume increases across our businesses. Now I will turn the call over to Vishal.